Content about Wyeth

November 1, 2010

Two months of Ratiopharm sales on the books and strong growth in the United States...

TEL AVIV, Israel Two months of Ratiopharm sales on the books and strong growth in the United States helped Teva beat third-quarter profit estimates, with sales up 20% to $4.25 billion, from $3.55 billion during the same period one year ago.

October 21, 2010

Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis...

PRINCETON, N.J. Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis said Thursday.

 

Sandoz announced the launch of piperacillin and tazobactam for injection. The drug is used to treat moderate to severe infections of bacteria resistant to piperacillin alone but vulnerable to the combination of the two drugs.

 

 

October 11, 2010

McNeil Consumer Healthcare recently parlayed its Tylenol brand franchise into external analgesics....

NEW YORK McNeil Consumer Healthcare recently parlayed its Tylenol brand franchise into external analgesics.

August 3, 2010

Pfizer had a big increase in sales and a modest increase in profits during second...

July 20, 2010

Pfizer is selling one of its New York properties to financial services firm TIAA-CREF, according...

July 18, 2010

A U.S. District Court has ruled in favor of two companies who alleged patent infringement...

June 6, 2010

Switch always has been the most significant driver of revenues within the non-prescription aisles, with...

June 6, 2010

While Big Pharma hurdles toward the edge of the patent cliff, some of the latest...

May 25, 2010

Pfizer has named Mikael Dolsten as its president for worldwide research and development, the drug...

May 16, 2010

A combination of patent expirations and rising levels of debt could put the drug industry’s...

May 11, 2010

Perrigo on Tuesday announced that David Kneisl has joined Perrigo as a customer business manager...

May 6, 2010

Pfizer reported $16.8 billion in revenues for first quarter 2010, a 54% increase over first...

March 14, 2010

Drug companies stand to lose a lot of money in the coming years, as the...

March 2, 2010

It appears that Pfizer has changed its mind a second time about buying Ratiopharm....

February 23, 2010

The Food and Drug Administration has approved a vaccine for preventing pneumococcal disease in children,...

February 3, 2010

Pfizer had some impressive results in the earnings report it released Wednesday, but the company...

January 26, 2010

Pfizer’s acquisition of Wyeth appears to be paying off for the world’s largest drug maker....

January 10, 2010

Sanofi-Aventis is the latest pharma powerhouse to make the move toward over-the-counter medicine with its...

December 20, 2009

This is further substantiation that the business of over-the-counter medicines, particularly those sold in the...

NEW YORK This is further substantiation that the business of over-the-counter medicines, particularly those sold in the U.S. market, is a key growth driver for pharma companies. If you weren’t convinced when Pfizer re-entered the OTC market with its acquisition of Wyeth, then you certainly should be convinced now.

 

October 18, 2009

What’s really intriguing behind the return of a consumer division to Pfizer is the fact...

NEW YORK What’s really intriguing behind the return of a consumer division to Pfizer is the fact that two of its flagship pharmaceuticals -- Lipitor and Viagra -- are approaching patent expiration, and both have been suggested as possible Rx-to-OTC switch candidates by Kline & Co.

 

August 30, 2009

Over-the-counter medicines save healthcare dollars. It’s certainly a value that consumers are taking advantage of...

NEW YORK Over-the-counter medicines save healthcare dollars. It’s certainly a value that consumers are taking advantage of in light of the current recession. According to this report, as well as others — i.e., the Kaiser Family Foundation polls — Americans are cost shifting from more expensive and more time-consuming (having to take time off of work to see a doctor) prescription therapies to OTC medicines.

 

March 12, 2009

The last few weeks have seen a lot of acquisition activity among large pharmaceutical companies....

The last few weeks have seen a lot of acquisition activity among large pharmaceutical companies.

 

First, Pfizer announced in January that it would acquire Wyeth for approximately $68 billion. This month saw three more mergers: Merck & Co.’s $41.1 billion purchase of Schering-Plough Corp., Roche’s $46.8 billion purchase of Genentech and Gilead Science’s purchase of CV Therapeutics.

 

January 29, 2009

The deal gives a great deal of added heft to Pfizer’s pharmaceutical division — the...

The deal gives a great deal of added heft to Pfizer’s pharmaceutical division — the combined Pfizer/Wyeth entity represents $70 billion in annual sales. Pfizer was already the leading pharmaceutical supplier at retail pharmacy for the 12 months ending November according to IMS Health. And that’s thanks in large part to the company’s Lipitor franchise. While Lipitor is the No. 1 drug sold in retail pharmacy today, the first patent protecting the statin expires as soon as 2010, though most analysts project a generic Lipitor will be introduced by November 2011.

October 14, 2007

The jury in the case between Wyeth and three Nevada women who claim Wyeth’s drug...